- Home
- MYSZ vs CRIS Comparison
MYSZ vs CRIS Comparison
Compare MYSZ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MYSZ | CRIS |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.3M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MYSZ | CRIS |
|---|---|---|
| Price | $1.67 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 675.0K | 132.7K |
| Earning Date | 04-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.40 | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | $142,000.00 | ★ $9,898,000.00 |
| Revenue This Year | $41.64 | $27.10 |
| Revenue Next Year | N/A | $67.74 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 125.40 | 31.50 |
| 52 Week Low | $0.33 | $0.18 |
| 52 Week High | $4.28 | $6.74 |
Technical Indicators
Market Signals| Indicator | MYSZ | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 19.02 |
| Support Level | $0.50 | $0.80 |
| Resistance Level | $2.60 | $1.04 |
| Average True Range (ATR) | 0.25 | 0.11 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 11.00 | 8.07 |
Price Performance
Historical ComparisonAbout MYSZ My Size Inc.
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.